Yang, Yeon-Suk
Xie, Jun http://orcid.org/0000-0001-9565-1567
Wang, Dan http://orcid.org/0000-0001-9079-2360
Kim, Jung-Min
Tai, Phillip W. L. http://orcid.org/0000-0001-7409-8344
Gravallese, Ellen
Gao, Guangping http://orcid.org/0000-0003-0097-9012
Shim, Jae-Hyuck
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR068983, R21AR072836, R21AR073331)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (P01AI100263, R01NS076991, P01HD080642, R01AI12135)
Article History
Received: 19 November 2018
Accepted: 29 May 2019
First Online: 4 July 2019
Competing interests
: G.G. and J.H.S. have submitted a patent application concerning the methodology described in this study. G.G. is a scientific cofounder of Voyager Therapeutics and Aspa Therapeutics Inc., and holds equity in these companies. G.G. is an inventor on patents with potential royalties licensed to Voyager Therapeutics, Aspa Therapeutics Inc., and other biopharmaceutical companies. The other authors declare no competing interests.